Who are Insight Molecular Diagnostics Inc.'s main suppliers?

Insight Molecular Diagnostics Inc. (IMDX) key suppliers include: BIO-RAD, Lineage Cell Therapeutics, Inc., Lineage Cell Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/IMDX.

Who are Insight Molecular Diagnostics Inc.'s major customers?

Insight Molecular Diagnostics Inc. (IMDX) key customers include: Quest Diagnostics Incorporated, Quest Diagnostics Incorporated, CAREDX-INC-NATERA-INC, CAREDX-INC-NATERA-INC-TRANSPLANT-GENOMICS-OMIXON, Bio-Rad Laboratories, Inc. and 1 more. View the full customer network at chainsifter.com/chain/IMDX.

What sector is Insight Molecular Diagnostics Inc. in?

Insight Molecular Diagnostics Inc. (IMDX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

IMDX Supply Chain: Insight Molecular Diagnostics Inc. Supplier List & 12 Relationships

3Suppliers

6Customers

3Debt Items

16Related Chains

Insight Molecular Diagnostics Inc. Suppliers

Ticker	Name	Confidence	Evidence
BIO-RAD	BIO-RAD	92%	The Company has a concentration in the volume of business transacted with Bio-Rad, its global strategic partner.
LCTX	Lineage Cell Therapeutics, Inc.	72%	ission or proceeding could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete directly with us, or reduce our ability t…
LCTX	Lineage Cell Therapeutics, Inc.	72%	Reciprocal relationship from LCTX graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from LCTX graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from LCTX g…

Insight Molecular Diagnostics Inc. Customers

Ticker	Name	Confidence	Evidence
DGX	Quest Diagnostics Incorporated	92%	On February 20, 2026, iMDx announced that it had entered into a Specimen Collection Agreement with Quest Diagnostics for certain specimen collection-related services related to the Company’s GraftAss…
DGX	Quest Diagnostics Incorporated	92%	Reciprocal relationship from DGX graph: Reciprocal relationship from IMDX graph: On February 20, 2026, iMDx announced that it had entered into a Specimen Collection Agreement with Quest Diagnostics f…
CAREDX-INC-NATERA-INC	CAREDX-INC-NATERA-INC	85%	izations that conduct research in our field. Our competition will be determined in part by the potential indications for which our lead test candidates are developed and ultimately marketed. Addition…
CAREDX-INC-NATERA-INC-TRANSPLANT-GENOMICS-OMIXON	CAREDX-INC-NATERA-INC-TRANSPLANT-GENOMICS-OMIXON	85%	izations that conduct research in our field. Our competition will be determined in part by the potential indications for which our lead test candidates are developed and ultimately marketed. Addition…
BIO	Bio-Rad Laboratories, Inc.	72%	s to raise capital to finance its operations. Item 1. Business. Overview We are a pioneering diagnostics technology company. Our mission is to democratize access to novel molecular diagnostic testing…
BIO	Bio-Rad Laboratories, Inc.	72%	Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO grap…

Insight Molecular Diagnostics Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
IMDX-DEBT	Debt stack $3.1M	90%	Market cache reports total debt of $3.1M.
IMDX-DEBT-10235	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2017-12-31.
IMDX-DEBT-10234	Warrants outstanding: 819767	90%	xbrl warrant detail from xbrl 2023-09-30.

Insight Molecular Diagnostics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Insight Molecular Diagnostics Inc..

Insight Molecular Diagnostics Inc. Ownership

Holder	Name	Confidence	Evidence
IMDX-OWNER-BROADWOOD-CAPITAL-INC	BROADWOOD CAPITAL INC	90%	13F overlay lists BROADWOOD CAPITAL INC as top holder; 43 tracked holders.

Insight Molecular Diagnostics Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MXCT	MaxCyte, Inc.	100.00	2
PSNL	Personalis, Inc.	100.00	2
HBIO	Harvard Bioscience, Inc.	100.00	2
IDXG	Interpace Biosciences, Inc.	100.00	2
LCTX	Lineage Cell Therapeutics, Inc.	100.00	1	['supplier']
DGX	Quest Diagnostics Incorporated	63.48	1	['customer']
QGEN	Qiagen N.V.	50.00	2
AWHL	Aspira Women's Health Inc.	50.00	2
GERN	Geron Corporation	50.00	2
NVO	Novo Nordisk A/S	50.00	2
FLGT	Fulgent Genetics, Inc.	50.00	2
RNLXY	Renalytix Plc	50.00	2
APLS	Apellis Pharmaceuticals, Inc.	50.00	2
PRPH	ProPhase Labs, Inc.	50.00	2
BIO	Bio-Rad Laboratories, Inc.	38.88	1	['customer']
PAYERS	PAYERS	37.71	2

Insight Molecular Diagnostics Inc. Supply Chain